The course of the pulmonary embolism in patients with oncological diseases
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Main Article Content
https://orcid.org/0000-0003-4105-1915
Abstract
The aim – to identify factors associated with in-hospital mortality among patients with acute pulmonary embolism (PE) and oncological diseases.
Materials and methods. A retrospective analysis of 647 medical records of patients with acute PE treated at one center from January 1, 2018, to January 1, 2020, was conducted. Among them, 115 patients had verified oncological diseases. PE diagnosis in all patients was confirmed by computed tomography and/or autopsy results. Alongside laboratory studies, patients underwent ultrasound examination.
Results and discussion. A comparative assessment of clinical and anamnestic parameters in patients with PE, depending on the presence of oncological diseases, was conducted. The analysis revealed that patients with PE associated with oncological process were on average 5 years older, with higher proportion of elderly patients, and less frequently had anamnestic episodes of venous thrombosis (13.9 % vs. 24.6 %), but predictably more often had additional risk factors, such as blood transfusions, central venous catheters, and laparoscopic interventions. According to the results of the multifactorial regression analysis, factors independently influencing the risk of in-hospital death in patients with acute PE and oncological diseases included decrease of blood pressure, saturation, an increase of the pulmonary artery pressure, leukocytosis and presence of atrial fibrillation. The ROC analysis results allowed determining threshold values of parametric indicators associated with the risk of death during the hospital period in a patient with PE and oncological diseases, i.e. blood pressure ≤ 105 mm Hg, SpO2 ≤ 87 %, pulmonary artery pressure
> 48 mm Hg, and leukocyte count > 9.8 109/l.
Conclusion. The risk factors of in-hospital death in patients with PE associated with oncological disease are atrial fibrillation, increased pulmonary artery pressure, leukocyte count, low blood pressure and saturation.
Article Details
Keywords:
References
Tseluyko VY, Yakovleva LM, Sukhova SM, Radchenko OV. Factors related to the improvement of the right ventricular function in patients with pulmonary embolism at short-term follow-up. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2022;8(1);42-7. https://doi.org/10.22141/2224-0586.18.1.2022.1457. Ukrainian.
Tseluyko VY, Yakovleva LM, Sukhova SM, Kinoshenko KYu, Radchenko OV, Vnukova AS. Clinical and anamnestic characteristics and risk factors in patients with acute pulmonary embolism among residents of Kharkiv. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2021;17(3);58-63. https://doi.org/10.22141/2224-0586.17.3.2021.234810. Ukrainian.
Tseluyko VY, Kurinna MV, Yakovleva LM. The level of C-reactive protein in patients with acute pulmonary embolism. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2023;19(5):322-31. https://doi.org/10.22141/2224-0586.19.5.2023.1607. Ukrainian.
Tseluyko VY, Yakovleva LM, Askierov RN, Kurinna MV, Kharchenko LV, Shylo NG. Risk stratification of poor short-term prognosis in patients with high-risk pulmonary embolism. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2023;19(5);361-9. https://doi.org/10.22141/2224-0586.19.5.2023.1612. Ukrainian.
Tseluyko VY, Kharchenko LV. Characteristics of the course acute thromboembolism of the pulmonary artery in women. The Journal of V.N. Karazin Kharkiv National University. Series «Medicine». 2023;(46):33-42. https://doi.org/10.26565/2313-6693-2023-46-04. Ukrainian.
Venoznyj tromboembolizm: diahnostyka, likuvannia, profilaktyka. Mizhdystsyplinarni klinichni rekomendatsii. Kyiv. 2013. 63 s. Ukrainian.
Medyko-sotsial'ni aspekty khvorob systemy krovoobihu (analitychno-statystychnyj posibnyk). Za red. Kovalenka VM., Kornats'koho VM. Kyiv. 2009. 147 s. Ukrainian.
Matviychuk BO, Fedchyshyn NR, Filyus VV, Stasiv TH, Stasyuk MP, Flyak YaI, Shykoryak OV. The risk of venous thromboembolism in patients of generalsurgery. Klinichna anatomiia ta operatyvna khirurhiia. 2010;9(4);55-8. Ukrainian.
Sigüenza P, López Núñez JJ, Falga Tirado C, Gómez-Cuervo C, Riera-Mestre A, Gil-Díaz A, Verhamme P, Montenegro AC, Barbagelata-López C, Imbalzano E, Monreal M. Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency. Thromb Haemost. 2023 Oct 13. https://doi.org/10.1055/a-2191-7510. Epub ahead of print. PMID: 37832588.
Jakobsen SS, Frøkjaer JB, Fisker RV, Kristensen SR, Thorlacius-Ussing O, Larsen AC. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper gastrointestinal cancer patients. J Thromb Thrombolysis. 2023 Oct 4. https://doi.org/10.1007/s11239-023-02897-5. Epub ahead of print. PMID: 37792208.
Lavikainen LI, Guyatt GH, Luomaranta AL, Cartwright R, Kalliala IEJ, Couban RJ, Aaltonen RL, Aro KM, Cárdenas JL, Devereaux PJ, Galambosi PJ, Ge FZ, Halme ALE, Haukka J, Izett-Kay ML, Joronen KM, Karjalainen PK, Khamani N, Oksjoki SM, Pourjamal N; ROTBIGGS Investigators; Singh T, Tähtinen RM, Vernooij RWM, Tikkinen KAO. Risk of Thrombosis and Bleeding in Gynecologic Cancer Surgery: Systematic Review and Meta-Analysis. Am J Obstet Gynecol. 2023 Oct 10:S0002-9378(23)00735-4. https://doi.org/10.1016/j.ajog.2023.10.006. Epub ahead of print. PMID: 37827272.
Liu M, Qiu X, Sun Y, Li Q, Wen J, Liu G, Yao Z, Zhu L. Intensify Standardized Anticoagulation for Cancer-Associated Pulmonary Embolism: From Single-Center Real-World Data. Clin Ther. 2023 Oct 12:S0149-2918(23)00378-8. https://doi.org/10.1016/j.clinthera.2023.09.014. Epub ahead of print. PMID: 37838562.
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society. Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
Mulder FI, Horváth-Puhó E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, Ay C, Büller HR, Sørensen HT. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021 Apr 8;137(14):1959-1969. https://doi.org/10.1182/blood.2020007338. PMID: 33171494.
Lavikainen LI, Guyatt GH, Luomaranta AL, Cartwright R, Kalliala IEJ, Couban RJ, Aaltonen RL, Aro KM, Cárdenas JL, Devereaux PJ, Galambosi PJ, Ge FZ, Halme ALE, Haukka J, Izett-Kay ML, Joronen KM, Karjalainen PK, Khamani N, Oksjoki SM, Pourjamal N; ROTBIGGS Investigators; Singh T, Tähtinen RM, Vernooij RWM, Tikkinen KAO. Risk of Thrombosis and Bleeding in Gynecologic Cancer Surgery: Systematic Review and Meta-Analysis. Am J Obstet Gynecol. 2023 Oct 10:S0002-9378(23)00735-4. https://doi.org/10.1016/j.ajog.2023.10.006. Epub ahead of print. PMID: 37827272.
Xiang L, Jin S, Yu Y, Wang D, Chen H. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis. BMC Cancer. 2023 Oct 3;23(1):933. https://doi.org/10.1186/s12885-023-11424-x. PMID: 37789268; PMCID: PMC10546706.
Napolitano M, Siragusa S. The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis. Cancers (Basel). 2023 Sep 20;15(18):4640. https://doi.org/10.3390/cancers15184640.
Catella-Chatron J, Merah A, De Magalhaes E, Moulin N, Accassat S, Duvillard C, Mismetti P, Bertoletti L. Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patients. Respir Med Res. 2019 Nov;76:34-7. https://doi.org/10.1016/j.resmer.2019.08.002.
Shalaby K, Kahn A, Silver ES, Kim MJ, Balakumaran K, Kim AS. Outcomes of acute pulmonary embolism in hospitalized patients with cancer. BMC Pulm Med. 2022 Jan 6;22(1):11. https://doi.org/10.1186/s12890-021-01808-9.
Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-74. https://doi.org/10.1182/bloodadvances.2020003442.
Girard P, Laporte S, Chapelle C, Falvo N, Falchero L, Cloarec N, Monnet I, Burnod A, Tomasini P, Boulon C, Debourdeau P, Boutruche B, Scotté F, Lamblin A, Meyer G. Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study. Thromb Haemost. 2022 Jan;122(1):151-7. https://doi.org/10.1055/a-1486-7497.
Khorana AA, Connolly GC. Assessing Risk of Venous Thromboembolism in the Patient with Cancer. J Clin Oncol. 2009 Oct 10;27(29):4839-47. https://doi.org/10.1055/10.1200/JCO.2009.22.3271.
Feusette P, Sacha J, Tukiendorf A, Cisowski M, Gierlotka M, Wolny-Rokicka E. Edyta Wolny-Rokicka Clinical manifestations of cancer in patients with acute pulmonary embolism J Cardiovasc Med (Hagerstown). 2023 Jul 1;24(7):406-13. https://doi.org/10.2459/JCM.0000000000001496.
Bertoletti L, Madridano O, Jiménez D, Muriel A, Bikdeli B, Ay C, Trujillo-Santos J, Bosevski M, Sigüenza P, Monreal M. Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020. JACC CardioOncol. 2023 Nov 15;5(6):758-72. https://doi.org/10.1016/j.jaccao.2023.09.003.
Becattini C, Cimini LA, Bassanelli G, Maggioni AP, Pomero F, Lobascio I, Enea I, Pomata DP, Ruggieri MP, Zalunardo B, Novelli A, Di Fusco SA, Triggiani M, Marzolo M, Fioravanti C, Agnelli G, Gonzini L, Gulizia MM; COPE Investigators. Acute pulmonary embolism and cancer: findings from the COPE study. Clin Res Cardiol. 2024 Feb;113(2):288-300. https://doi.org/10.1007/s00392-023-02323-z.
Casazza F, Becattini C, Rulli E, Pacchetti I, Floriani I, Biancardi M, Scardovi AB, Enea I, Bongarzoni A, Pignataro L, Agnelli G. Clinical presentation and in-hospital death in acute pulmonary embolism: does cancer matter? Іntern Emerg Med . 2016 Sep;11(6):817-24. https://doi.org/10.1007/s11739-016-1431-9.
Nguyen E, Caranfa JT, Lyman GH, Kuderer NM, Stirbis C, Wysocki M, Coleman CI, Weeda ER, Kohn CG. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2018 Feb;16(2):279-92. https://doi.org/10.1111/jth.13921.
Ye L, Xie H, Lai M, Zheng G, Xie Y, Liu X. Risk factors for patients with acute hospital-acquired symptomatic pulmonary thromboembolism. Sci Rep. 2023 May 9;13(1):7552. https://doi.org/10.1038/s41598-023-34589-8.
Sørensen HT, Pedersen L, van Es N, Büller HR, Horváth-Puhó E. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. Lancet Reg Health Eur. 2023 Sep 28:34:100739. https://doi.org/10.1016/j.lanepe.2023.100739.
Nov Dong HY, Tong MS, Wang J, Liu Y, Tao GY, Petersen RH, Jara-Palomares L, Wang Y, Sun YB, Chen J. Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study. Transl Lung Cancer Res. 2023 Jul 31;12(7):1539-48. https://doi.org/10.21037/tlcr-23-346.
Jiarui Zhang, Adila Ali, Yu Liu, Lige Peng, Jiaqi Pu, Qun Yi, Haixia Zhou. Additive prognostic value of serum calcium to the ESC risk stratification in patients with acute pulmonary embolism. Thromb J. 2023 Feb 15;21(1):20. https://doi.org/10.1186/s12959-023-00461-y.